Enzerna Biosciences Email Format
Biotechnology ResearchNorth Carolina, United States2-10 Employees
Enzerna Biosciences, Inc. is a pre-clinical biotechnology company focused on developing long-term curative gene therapies for rare genetic disorders, leveraging its proprietary RNA editing technology. Its work targets patients with genetic conditions where durable correction could offer lasting therapeutic benefit, addressing unmet needs in the field of genetic medicine. Based in Morrisville, North Carolina, the company operates within the biotechnology research industry and sits at an early stage of development, with a small team dedicated to advancing foundational science toward potential clinical translation. The firm’s activities are centered on creating innovative therapies at the pre-clinical level, and it may pursue collaborations or partnerships to progress its research, as suggested by its scale and positioning within the sector.